Conrad Wai - Jul 31, 2025 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
CEO, Counterpart Health
Signature
/s/ Peter J. Rivas as attorney-in-fact for Conrad Wai
Stock symbol
CLOV
Transactions as of
Jul 31, 2025
Transactions value $
-$80,718
Form type
4
Date filed
8/4/2025, 04:45 PM
Previous filing
Jul 24, 2025
Next filing
Sep 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wai Conrad CEO, Counterpart Health C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai 2025-08-04 0001971702

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Tax liability -$80.7K -27.9K -1.64% $2.89 1.67M Jul 31, 2025 Direct F1
holding CLOV Class A Common Stock 1.4M Jul 31, 2025 By Trust. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.
F2 Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.